19540755-vitamin-c

7/27/2019 19540755-Vitamin-C

http://slidepdf.com/reader/full/19540755-vitamin-c 1/2

7/27/2019 19540755-Vitamin-C

http://slidepdf.com/reader/full/19540755-vitamin-c 2/2

experimental. As a starting point for anyone considering intravenous vitamin C as an option in

Cancer, we recommend you discuss the articles below with a health professional, oncologist or 

doctor at our clinic.

Riordan NH, Riordan HD, Hunninghake RE. (1997) Intravenous Ascorbate as a

Chemotherapeutic and Biologic Response Modifying Agent. RECNAC Project.

Gonzalez et al. (2005) Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years

 Later. Integrat Cancer Ther 4(1):32-44. 

Padayatty et al. (2004) Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use. 

Ann Intern Med 140(7):533-537. 

Chen et al. (2005) Pharmacological concentrations of ascorbic acid selectively kills cancer 

cells: Action as a pro-drug to deliver hydrogen peroxide to tissues.  PNAS 102:13604-13609.